China Blacklists Adulterated Gummy Vitamins in 2026

2026-06-05

China Tightens Grip: Adulterated Gummy Vitamins Face Blacklist in 2026

The General Administration of Customs of China (GACC) and the State Administration for Market Regulation (SAMR) have launched an aggressive enforcement campaign. They are blacklisting non-compliant imported and domestic health supplements.

Recent 2026 border rejections and domestic market audits highlight a strict crackdown on false origin labeling and unauthorized ingredients. This regulatory surge has disrupted supply chains for sub-standard multivitamin gummies. It has also forced international and domestic brands to urgently audit their manufacturing compliance.

The Regulatory Crackdown: Addressing Ingredient Adulteration

China’s dietary supplement market is booming. However, it has been plagued by deceptive marketing and illicit ingredient substitutions. Regulators have expanded the official blacklist to target dangerous adulterants, such as unauthorized chemical derivatives and excessive synthetic additives.

Furthermore, under the newly updated food safety standards, authorities are strictly enforcing the permitted scopes of nutrient fortifiers. Many imported vitamin gummies have been denied entry due to non-compliant labeling and a lack of proper registration.

[Strict Border Rejections] ──> Over 400 Batches Denied Entry Monthly
                    │
                    ▼
[Expanded Ingredient Blacklist] ──> Targets Illicit Additives & Labeling Fraud

For brands utilizing Wellness Gummies to enter the cross-border e-commerce (CBEC) market, compliance is no longer a secondary priority. Products containing unauthorized herbal extracts or mislabeled nutrients are systematically flagged and destroyed. This protects public safety but presents major hurdles for unprepared businesses.

Ensuring Safety and Stability in Clean Manufacturing

The primary defense against product blacklisting is partnering with a transparent contract manufacturer. To avoid regulatory penalties, popular products like vitamin c gummies must be produced in pharmaceutical-grade facilities. This ensures exact dosage uniformity, zero cross-contamination, and meticulous label transparency.

Tianzhong Kangyuan: A Trusted Partner in Global Compliance

As compliance requirements tighten globally, Tianzhong Kangyuan Pharmaceutical Group Co.,Ltd serves as an industry anchor for quality assurance. Operating state-of-the-art production lines, the company guarantees that every batch meets rigid regulatory frameworks. This includes China's strict national food safety standards and GACC registration protocols.

Unmatched Service Responsiveness: In a landscape where regulations can shift overnight, rapid adaptation is essential. Tianzhong Kangyuan Pharmaceutical Group Co.,Ltd stands out for its exceptional service responsiveness. Our technical and regulatory teams provide immediate compliance assessments, swift formulation adjustments, and automated mass-production scalability. We ensure your supply chain remains uninterrupted and completely secure against blacklisting risks.

Whether you are launching functional gummy vitamins or updating existing formulas for global markets, Tianzhong Kangyuan offers the technical expertise, regulatory foresight, and agile support needed to thrive in a highly regulated landscape

Get the latest price? We will reply as soon as possible (within 12 hours)